US FDA accepts for review Dr Reddy’s BLA for proposed interchangeable biosimilar, abatacept: Our Bureau, Bengaluru Monday, February 23, 2026, 12:20 Hrs [IST] Dr Reddy’s Labora ...
Skoda Auto India recently revealed the new Skoda Kushaq facelift SUV in the Indian market. The company has now announced that production of the update.
The News-Herald on MSN
Roosevelt boys bowling captures D1 regional title; 7 other local teams and 23 individuals also qualify for states
The first stretch of the Michigan high school bowling postseason wrapped up on Saturday with team and individual regional tournaments taking place across the state. A wave of Downriver area teams were ...
USFDA accepts for review Dr Reddy's biologics license application for Orencia biosimilar DRL_AB Swati Bharadwaj Hyderabad: Dr Reddy’s Laboratories Ltd.
The US Food and Drug Administration (USFDA) has greenlit Dr Reddy's Biologics License Application for a proposed biosimilar to Orencia (abatacept).
The Norton Atlas is a middle-weight adventure motorcycle which will compete against rivals like the Kawasaki Versys 650.
Dr. Reddy's receives USFDA approval for a biosimilar to Orencia, targeting arthritis treatment with a cost-effective infusion option.
Hyderabad: Dr. Reddy's Laboratories Ltd. has received acceptance from the U.S. Food and Drug Administration to review its 351(k) Biologics License Application (BLA) for DRL_AB, a ...
Dr. Reddy’s announces USFDA acceptance to review its Biologics License Application (BLA) for proposed interchangeable biosimilar, Abatacept.
Dr. Reddy’s Laboratories (RDY) stock is in focus as the FDA agrees to review its biosimilar targeting Bristol Myers' (BMY) ...
Novartis AG’s exit from its listed Indian subsidiary highlights a growing trend of "Big Pharma" companies divesting from the hyper-competitive Indian market.
The integration of deep reinforcement learning with PD control in humanoid robots enhances gait stability and patient comfort during lower limb rehabilitation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results